EMD Serono, USA
Merck KGaA, Darmstadt, Germany
Merck KGaA, Darmstadt, Germany

Culture & Capabilties

Culture & Capabilties

Partnership - Bring Innovation to Life
We are dedicated to extend our access to the world of scientific and product innovation beyond our own laboratories.
We are committed to broaden access with external communities, fostering our professional relationships with respect and focus, passion and commitment.

"Creating an effective partnership means for us to combine the strengths of Merck KGaA, Darmstadt, Germany and our partner to unlock the knowledge and insights of both partners."

Stefan Oschmann, Vice Chairman of the Executive Board and Deputy CEO of Merck KGaA, Darmstadt, Germany 

As a business of Merck KGaA, Darmstadt, Germany, we offer the financial stability and long term vision of a family owned company.

Our company structure allows us to think beyond the next quarter's earnings and to make the right choices for our patients and partners. Our solid foundation, combined with a certain flexibility as a mid-size biopharmaceutical player, enables us to bring to life our commitment to transform lives through medical science.

• Merck KGaA, Darmstadt, Germany is the world’s oldest pharmaceutical and chemical company – since 1668, the company has stood for innovation, business success and responsible entrepreneurship.

• Merck KGaA, Darmstadt, Germany is a publicly listed company. The Merck family holds 70% of the shares.

The biopharmaceutical division is Merck KGaA, Darmstadt, Germany’s largest business with sales of €6.9  billion in 2015, and approximately 16,000 employees worldwide.
It is internationally recognized as a biotechnology leader, with innovative and successful products along with a promising development pipeline. Its products are commercialized in 150 countries.

“Successful partnering requires active listening, commitment from the parties and above all mutual trust."

Belén Garijo, Member Executive Board and Chief Executive Officer Healthcare of Merck KGaA Darmstadt, Germany

People and relationships matter

We are committed to success through partnerships. We achieve this through dedicated alliance managers, joint project teams, a governance structure facilitating decision making, open communications and an unfailing pursuit of common goals.

We are proud of our strong network of alliances with other biotech companies and academic groups.

“In order to deliver on our promise of bringing novel therapies from our pipeline to patients in need, we continue to invest in our internal innovation capabilities, while leveraging the expertise and experience of our external partners.”

Luciano Rossetti, Executive VP, Global Research & Development

We believe in our R&D engine

• € 1,7 billion invested in R&D in 2015

• Almost 2,300 professionals worldwide in R&D

• R&D activities structured around highly connected hubs as centers of excellence

Global Business Development is a driving force of growth and competitive advantage.

• We have 100 ongoing strategic collaborations and alliances in key business development areas

• € 150 million managed by MS Ventures to access early innovation

Self-initiative, creativity, and innovation is written in bold.

• Supporting scientists, students, entrepreneurs, employees and their innovative ideas in many ways by giving grants, offering awards, sponsoring initiatives

• Global Grants Program with annual €20 million investment to advance innovation and medical education

“In a collaborative and innovative culture, we combine our internal capabilities and expertise with leading external enterprises.”

Philippe Lopes-Fernandes, Senior Vice President & Head of Global Business Development & Alliance Management

World class capabilities from R&D, manufacturing to marketing

We discover, develop, manufacture and market prescription medicines of both chemical and biological origin. As a midsize company, we offer our partners the flexibility, agility and lean structures of a biotech company, while providing global reach and large scale capabilities.

• Globally integrated hubs for R&D, with a strong network of alliances

• A balanced R&D portfolio of small molecules and biologics, built on a broad technological base

• Strategically focused on stratified medicinewith multiple diagnostic partnerships

• Years of experience in building medical device platforms to deliver better health outcomes

• World class pilot plants to full scale commercial production facilities across four continents

• Offering leading brands in 150 countries

• Actively marketing pharmaceutical products not only in mature markets, but as well in the emerging markets for decades

Embracing all partnering activities from identification of new opportunities, licensing, investments up to alliance management with highest professionalism, and passion

• Unparalleled track record for stringent due diligence and targeted partnering

• Alliance management group to maximize the value of our alliances


  • known for Innovation, Quality, Performance & Efficiency
  • liked for Customer Orientation, Entrepreneurial Spirit, Career Opportunities
  • respected for Values, Responsibility & Sustainability, Thinking beyond Generations